Skip to main content

Advertisement

Log in

Despite Equivalent Outcomes, Men Receive Neoadjuvant Chemotherapy Less Often Than Women for Lymph Node-Positive Breast Cancer

  • ASO Visual Abstract
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Funding

This research did not receive any specific funding from agencies in the public, commercial or nonprofit sectors except the institutional funds made available to the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Megan E. Miller MD FACS.

Ethics declarations

Disclosure

This study will be presented in e-Poster format at the Society of Surgical Oncology International Conference on Surgical Cancer Care, March 18-19, 2021. The authors have no conflicts of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cao, L., Hue, J.J., Freyvogel, M. et al. Despite Equivalent Outcomes, Men Receive Neoadjuvant Chemotherapy Less Often Than Women for Lymph Node-Positive Breast Cancer. Ann Surg Oncol 28 (Suppl 3), 438–439 (2021). https://doi.org/10.1245/s10434-021-09994-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-021-09994-w

Navigation